Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

NCT00003062 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: temozolomide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC